Analysis of the tumor-infiltrating CD4 T-cell population also showed low expression of Tim-3, LAG3, BTLA and CD160 (mean<1%) and CD244 was found on 4.6% of tumor-infiltrating CD4 T cells, with no significant differences in expression identified between blood, NS and cSCC (online supplemental figure 7). This evidence concerns the gene CD160 and neoplasm.